search
Back to results

Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome (MRKH)

Primary Purpose

Rokitansky Syndrome, Surgical or Vaginal Dilatation of Vaginal Aplasia

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
evaluate quality of life of surgical and non surgical vaginal aplasia
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Rokitansky Syndrome focused on measuring Rokitansky syndrome, surgical or vaginal dilatation of vaginal aplasia, quality of global and sexual life

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient affected with Rokitansky syndrome
  • Patient over 18 years old
  • Patient care with dilatations or by surgery since 1995
  • Patient having started dilatations or having had surgery since at least one year
  • Patient who signed the consent
  • French patient
  • Women with social welfare

Exclusion Criteria:

  • Patient with a serious chronic disease interfering with analysis to be performed in this project.
  • Patient can't reading or writing
  • Patient with legal protection

Sites / Locations

  • Service d'Endocrinologie et Gynécologie Pédiatriques Hôpital Necker Enfants Malades

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Patients with a Rokitansky Syndrome

Arm Description

Patients with a Rokitansky Syndrome

Outcomes

Primary Outcome Measures

Assessment of quality of global life
To fill a self-administered questionnaire: the World Health Organization Quality Of Life (general scale WHOQOL)

Secondary Outcome Measures

Assessment of quality of sexual life
To fill 2 self-administered questionnaires : Female Sexual Function Index and Female Sexual Dysfunction Scale-Revised (FSFI and FSDS)
Assessment of anatomic results
Gynaecological examination
Assessment of social integration
To fill a self-administered questionnaire (marital status, occupational group, education level, employment status)

Full Information

First Posted
July 26, 2013
Last Updated
April 16, 2021
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT01911884
Brief Title
Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome
Acronym
MRKH
Official Title
Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
October 11, 2012 (Actual)
Primary Completion Date
April 10, 2015 (Actual)
Study Completion Date
April 10, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The principal objective is to assess the general health status and the sexual health status of women with Rokitansky syndrome having received a surgical or non surgical treatment. The secondary purpose is to assess the anatomical aspect and the quality of sexual life. To search a correlation between the anatomical result, the general and sexual quality of life. To compare the different techniques of medical follow-up in terms of anatomic results, general quality of life, sexual quality of life, complications and morbidities. To evaluate social inclusion of these women with their family situation, social and professional category and their job. At the same time, we propose an evaluation with a psychologist to study the impact of the announcement of the diagnosis. This impact study is conducted at a distance from diagnosis.
Detailed Description
The MRKH syndrome is a congenital disorder characterized by absence of uterus and at least the two thirds of the vagina, a female phenotype and a normal karyotype XX. These patients have normal ovaries and fallopian tubes. The external genitalia are normal. This syndrome was described by Mayer (1829), Rokitansky ( 1838), Kuster ( 1910) and Hauser ( 1961). About one in every 4500 female babies has this condition. This syndrome represents 85% of congenital vagina aplasia and is the second cause of primary amenorrhea after disorders of sexual development. These women are unfertile. The malformation can be isolated or associated with other malformations called MURCS (Müllerian duct aplasia, renal aplasia, and cervicothoracic somite dysplasia), as kidney ( 30%), bone ( 10%) or cardiac malformations ( 1%). The most common age for MRKH to be diagnosed is when the woman hasn't started her period ( 85%).Some girls may find out at an earlier age when there is a severe malformation , during a systematic gynaecological examination or during an pelvic ultrasound. When the women are older, the syndrome can be diagnosed during studies for infertility. A pelvic ultrasound is usually the first test performed to assess presence of uterus. A magnetic resonance imaging may be used to complete the investigations. These tests can also confirm if there are two ovaries and two kidneys. Sometimes, a very small uterus can be seen, it's a uterine horn. The psychological management is essential to take care of the women affected.It seeks to understand the impact of the diagnosis announcement and the various treatments offered. The follow-up can be different for each girl and her parents during several appointments. Therapeutic management can be proposed when the girl is ready because the therapeutic is long and difficult. Two therapeutic approaches can be proposed: to create a vagina using dilators or having a surgical procedure. In France, vaginal reconstruction with dilators is the most used. This method consists in dilating the vagina progressively with different sizes of dilators in order to obtain a vaginal opening of 8 cm around 6 months after treatment initiation. This method is successful in about 75% of cases. Complications are exceptional. Surgery is an option for patients who are unsuccessful with dilatators or patients who prefer surgery. A number of operations are appropriate for the correction of vaginal agenesis. Vecchietti procedure and sigmoid vaginoplasty are the most commonly used techniques in France. In national and international publications, it is impossible to compare scientifically the results of the different technique because of the small effective in each studies and because of the the lack of standardized assessment. Studies report the functional result for each technique but none compare the techniques used. No studies compared the result in terms of anatomical and function results, complications and quality of life. The demonstration of a positive correlation between the anatomic criteria and the functional results would help to guide the surgical technique. The lack of correlation would suggest that a perfect anatomical reconstruction is not essential. If it is demonstrated, the management should focus on other criteria like psychological management. Several factors seem to influence the general and sexual quality of life of women affected by the Rokitansky syndrome. Our objective is to evaluate the importance of these factors to improve the treatment of these women.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rokitansky Syndrome, Surgical or Vaginal Dilatation of Vaginal Aplasia
Keywords
Rokitansky syndrome, surgical or vaginal dilatation of vaginal aplasia, quality of global and sexual life

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
138 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients with a Rokitansky Syndrome
Arm Type
Other
Arm Description
Patients with a Rokitansky Syndrome
Intervention Type
Behavioral
Intervention Name(s)
evaluate quality of life of surgical and non surgical vaginal aplasia
Intervention Description
protocol designed to evaluate quality of life of surgical and non surgical vaginal aplasia
Primary Outcome Measure Information:
Title
Assessment of quality of global life
Description
To fill a self-administered questionnaire: the World Health Organization Quality Of Life (general scale WHOQOL)
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Assessment of quality of sexual life
Description
To fill 2 self-administered questionnaires : Female Sexual Function Index and Female Sexual Dysfunction Scale-Revised (FSFI and FSDS)
Time Frame
Day 0
Title
Assessment of anatomic results
Description
Gynaecological examination
Time Frame
Day 0
Title
Assessment of social integration
Description
To fill a self-administered questionnaire (marital status, occupational group, education level, employment status)
Time Frame
Day 0

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient affected with Rokitansky syndrome Patient over 18 years old Patient care with dilatations or by surgery since 1995 Patient having started dilatations or having had surgery since at least one year Patient who signed the consent French patient Women with social welfare Exclusion Criteria: Patient with a serious chronic disease interfering with analysis to be performed in this project. Patient can't reading or writing Patient with legal protection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michel POLAK, PUPH
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service d'Endocrinologie et Gynécologie Pédiatriques Hôpital Necker Enfants Malades
City
Paris
ZIP/Postal Code
75015
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
30036500
Citation
Cheikhelard A, Bidet M, Baptiste A, Viaud M, Fagot C, Khen-Dunlop N, Louis-Sylvestre C, Sarnacki S, Touraine P, Elie C, Aigrain Y, Polak M; French MRKH Study Group. Surgery is not superior to dilation for the management of vaginal agenesis in Mayer-Rokitansky-Kuster-Hauser syndrome: a multicenter comparative observational study in 131 patients. Am J Obstet Gynecol. 2018 Sep;219(3):281.e1-281.e9. doi: 10.1016/j.ajog.2018.07.015. Epub 2018 Jul 21.
Results Reference
result

Learn more about this trial

Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome

We'll reach out to this number within 24 hrs